Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty
Authors:
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 65 (2) , 558-570.e10
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Drug-coated balloons and their place in treating peripheral arterial diseaseExpert Review of Medical Devices, 2013
- Peripheral Applications of Drug-Coated Balloons: Past, Present and FutureCardioVascular and Interventional Radiology, 2012
- Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2012
- One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2008
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)European Journal of Vascular and Endovascular Surgery, 2007
- The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study designAmerican Heart Journal, 2006
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Prevalence of peripheral arterial disease: persistence of excess risk in former smokersAustralian and New Zealand Journal of Public Health, 2002
- Revealing the cost of Type II diabetes in EuropeDiabetologia, 2002
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985